LUNG
Pulmonx Corp

648
Mkt Cap
$72.18M
Volume
521,263.00
52W High
$9.37
52W Low
$1.31
PE Ratio
-1.24
LUNG Fundamentals
Price
$1.89
Prev Close
$1.75
Open
$1.78
50D MA
$1.68
Beta
1.20
Avg. Volume
1.15M
EPS (Annual)
-$1.44
P/B
1.20
Rev/Employee
$287,934.71
Loading...
Loading...
News
all
press releases
Pulmonx Corporation $LUNG Shares Sold by Primecap Management Co. CA
Primecap Management Co. CA trimmed its position in shares of Pulmonx Corporation (NASDAQ:LUNG - Free Report) by 4.6% in the second quarter, according to its most recent filing with the Securities and...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded Pulmonx from a "sell" rating to a "hold" rating in a report on Sunday...
MarketBeat·18d ago
News Placeholder
Pulmonx (NASDAQ:LUNG) Receives "Buy" Rating from D. Boral Capital
D. Boral Capital reiterated a "buy" rating and set a $14.00 price target on shares of Pulmonx in a research note on Thursday...
MarketBeat·19d ago
News Placeholder
Pulmonx (NASDAQ:LUNG) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS
Pulmonx (NASDAQ:LUNG - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.40) by $0.06. The...
MarketBeat·20d ago
News Placeholder
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of +15.00% and +4.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
Pulmonx's Earnings: A Preview
read more...
Benzinga·22d ago
News Placeholder
Pulmonx Corporation (NASDAQ:LUNG) Receives Average Recommendation of "Hold" from Analysts
Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) has received an average recommendation of "Hold" from the ten brokerages that are presently covering the company, MarketBeat.com reports. One...
MarketBeat·26d ago
News Placeholder
American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates
American Well (AMWL) delivered earnings and revenue surprises of +4.92% and +3.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·29d ago
News Placeholder
What Makes Pulmonx (LUNG) a New Buy Stock
Pulmonx (LUNG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·3mo ago
News Placeholder
After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG)
Pulmonx (LUNG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks·4mo ago

Latest LUNG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.